Cargando…

Leflunomide treatment for patients hospitalised with COVID-19: DEFEAT-COVID randomised controlled trial

OBJECTIVE: To evaluate the clinical efficacy and safety of leflunomide (L) added to the standard-of-care (SOC) treatment in COVID-19 patients hospitalised with moderate/critical clinical symptoms. DESIGN: Prospective, open-label, multicentre, stratified, randomised clinical trial. SETTING: Five hosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kralj-Hans, Ines, Li, Kuo, Wesek, Adrian, Lamorgese, Alexia, Omar, Fatima, Ranasinghe, Kapila, McGee, Megan, Brack, Kieran, Li, Shiliang, Aggarwal, Ritesh, Bulle, Ajay, Kodre, Aparna, Sharma, Shashank, Fluck, David, John, Isaac, Sharma, Pankaj, Belsey, Jonathan D, Li, Ling, Seshasai, Sreenivasa Rao Kondapally, Li, Hong Lin, Marczin, Nandor, Chen, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105917/ https://www.ncbi.nlm.nih.gov/pubmed/37055207 http://dx.doi.org/10.1136/bmjopen-2022-068179

Ejemplares similares

Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study
por: Danese, Mark D, et al.
Publicado: (2017)

Quantifying the Excess Risk of Adverse COVID-19 Outcomes in Unvaccinated Individuals With Diabetes Mellitus, Hypertension, Ischaemic Heart Disease or Myocardial Injury: A Meta-Analysis
por: Ng, Sher May, et al.
Publicado: (2022)

Markers of Dysglycaemia and Risk of Coronary Heart Disease in People without Diabetes: Reykjavik Prospective Study and Systematic Review
por: Sarwar, Nadeem, et al.
Publicado: (2010)

Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK
por: Danese, Mark D, et al.
Publicado: (2016)

Premature morbidity and mortality associated with potentially undiagnosed familial hypercholesterolemia in the general population
por: Ray, Kausik K., et al.
Publicado: (2023)

Investigation of Cardiovascular Health and Risk Factors Among the Diverse and Contemporary Population in London (the TOGETHER Study): Protocol for Linking Longitudinal Medical Records
por: Dharmayat, Kanika, et al.
Publicado: (2020)

Use of leflunomide in patients with chronic hypersensitivity pneumonitis
por: Noh, Sungryong, et al.
Publicado: (2020)

ERAS in Cardiac Surgery: Wishful Thinking or Reality
por: Demir, Z. Aslı, et al.
Publicado: (2023)

Leflunomide-Induced Hidradenitis Suppurativa
por: Machan, Achraf, et al.
Publicado: (2020)

Defeating Paediatric Tuberculous Meningitis: Applying the WHO “Defeating Meningitis by 2030: Global Roadmap”
por: Basu Roy, Robindra, et al.
Publicado: (2021)

Defeat
por: Niburski, Kacper
Publicado: (2023)

Lockdown—the only solution to defeat COVID-19
por: Gupta, Abhishek, et al.
Publicado: (2020)

Amelioration of Experimental Autoimmune Uveitis by Leflunomide in Lewis Rats
por: Fang, Cheng-bo, et al.
Publicado: (2013)

Can biowarfare agents be defeated with light?
por: Vatansever, Fatma, et al.
Publicado: (2013)

Leflunomide leads to inhibition of transendothelial migration
por: Grisar, J, et al.
Publicado: (2001)

Treatment of refractory lupus nephritis using leflunomide: A prospective study
por: Zhang, Shuo, et al.
Publicado: (2023)

Immune to defeat
por: Reese, Michael L
Publicado: (2013)

The Defeat of the Bill
Publicado: (1894)

Defeat Such Legislation
Publicado: (1901)

Efficacy and Safety of Leflunomide for Refractory COVID-19: A Pilot Study
por: Wang, Qiang, et al.
Publicado: (2021)

8. Myositis as an idiosyncratic drug reaction to leflunomide
por: Darren, Angeline, et al.
Publicado: (2019)

Wnt defeats death
por: Wells, William A.
Publicado: (2002)

Defeating cancer with antidepressants
por: Lieb, J
Publicado: (2008)

Defeater Goes External
por: Janvid, Mikael
Publicado: (2017)

Osteopathy Bill Defeated
Publicado: (1905)

Current Perspectives and Future Directions in Lung Transplantation
por: Verzelloni Sef, Alessandra, et al.
Publicado: (2023)

Defeating epilepsy: A global public health commitment
por: Saxena, Shekhar, et al.
Publicado: (2017)

Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy
por: Shang, Shunlai, et al.
Publicado: (2022)

Differential effects of leflunomide and methotrexate on cytokine production in RA
por: Kraan, MC, et al.
Publicado: (2003)

Formation of multiple pulmonary nodules during treatment with leflunomide
por: Yoshikawa, Gilberto Toshikawa, et al.
Publicado: (2015)

A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs
por: Sato, M., et al.
Publicado: (2017)

Leflunomide for BKvirus: Report of Seven Kidney-Transplanted Children
por: Launay, M., et al.
Publicado: (2018)

Leflunomide therapy for IgA vasculitis with nephritis in children
por: Hou, Ling, et al.
Publicado: (2021)

Leflunomide: COVID-19 infection: 4 case reports
Publicado: (2021)

Efficacy of Leflunomide, Telmisartan, and Clopidogrel for Immunoglobulin A Nephropathy: A Randomized Controlled Trial
por: Wu, Jie, et al.
Publicado: (2016)

Synergy and Mechanism of Leflunomide Plus Fluconazole Against Resistant Candida albicans: An in vitro Study
por: Li, Xiuyun, et al.
Publicado: (2023)

Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients
por: Huang, Xin, et al.
Publicado: (2022)

Defeating cancer with early detection
Publicado: (2003)

SUMO defeats protein aggregates
por: Leslie, Mitch
Publicado: (2011)

Are ethics promulgations self-defeating?
por: Gray, Derrick
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pouccafp7bu3uhughabr7tlp9a